D7081ZZ
Beam Radiation Lymphatics, Inguinal to None with None, Photons 1 - 10 MeV Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | 7 Lymphatic and Hematologic System |
| Operation | 0 Beam Radiation |
| Body Part | 8 Lymphatics, Inguinal |
| Approach | 1 Photons 1 - 10 MeV |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Beam radiation to the lymphatic and hematologic system delivers external radiation, typically from a linear accelerator, to lymph node regions or hematologic tissue affected by cancers such as Hodgkin lymphoma, non-Hodgkin lymphoma, or localized involvement from leukemia. Treatment is usually planned as a fractionated course given over several weeks, with the total dose divided into smaller daily sessions to maximize tumor control while allowing normal tissue to recover between treatments.
It is used both as primary therapy for certain lymphomas confined to specific nodal regions and as consolidation after chemotherapy to eliminate residual disease in previously bulky sites. Patients typically receive planning imaging beforehand to map the treatment field precisely to the involved nodal chain.
Anatomy & Axis Detail
Lymphatics, Inguinal
Inguinal lymphatics sit superficially in the groin and drain the vulva, penis, scrotum, anus, and lower extremity skin, making them a target when melanoma, vulvar cancer, penile cancer, or anal cancer spreads to this basin. Beam radiation to the groin nodes is technically distinct from deeper pelvic fields because the superficial location requires bolus material or electron components to ensure adequate skin and subcutaneous dose, while still limiting exposure to the underlying femoral vessels and hip joint. Skin reaction in this region tends to be more pronounced than in deeper sites due to skin folds and moisture, which affects both treatment tolerance and wound healing if surgery has preceded or will follow. Documentation should note whether treatment is confined to the inguinal nodes or extends to the pelvic chain above.
Modality Qualifier: Photons 1 - 10 MeV
Photons 1 to 10 MeV identifies radiation therapy delivered using megavoltage photon beams in this energy range, the standard produced by most modern linear accelerators for treating deeper tumors with better skin sparing and dose distribution than lower-energy beams. It is distinguished from the sub-1 MeV range used for superficial treatment and represents the energy band applied to the majority of external beam courses.
Coding & Documentation
Coders need documentation specifying the treatment site (a named lymph node region, spleen, or other hematologic structure), the modality as external beam, and the qualifier describing the type of beam, such as photon or electron therapy, drawn from the radiation oncology treatment plan and daily treatment records.
A common error is coding the diagnosis-driven anatomic site rather than the actual field treated, since radiation fields are often described in oncology shorthand like "mantle field" or "involved-site radiotherapy" that must be translated to the correct body part value. Failing to capture the correct qualifier for beam type is another frequent gap when the treatment summary isn't reviewed closely.